Morrison Foerster Advises Pacifico Biolabs on its Series A Financing Round

Morrison Foerster (“MoFo”) is advising Pacifico Biolabs GmbH (“Pacifico”), a Berlin-based food biotech company, on its Series A financing round.

Founded in 2022, Pacifico is pioneering the development of alternative protein ingredients using microbial fermentation. By leveraging a decades-old fermentation approach with modern biotechnology, the company produces scalable, cost-efficient protein alternatives designed to address the growing global demand for sustainable nutrition.  The proceeds of the Series A financing will support Pacifico’s scale-up efforts, including the expansion of its production capabilities.

Morrison Foerster has extensive experience advising high-growth companies, investors, and strategic partners in the life sciences and food + agritech sector, cross-border transactions, including venture capital financings.

Morrison Foerster’s Berlin team was led by Corporate/M&A Counsel Monika Obal and Technology & Transactions Partner Wolfgang Schönig.